Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

45 results about "Glycosphingolipid" patented technology

Glycosphingolipids are a subtype of glycolipids containing the amino alcohol sphingosine. They may be considered as sphingolipids with an attached carbohydrate. Glycosphingolipids are a group of lipids (more specifically, sphingolipids) and are a part of the cell membrane. They consist of a hydrophobic ceramide part and a glycosidically bound carbohydrate part. This oligosaccharide content remains on the outside of the cell membrane where it is important for biological processes such as cell adhesion or cell–cell interactions. Glycosphingolipids play also important role in oncogenesis and ontogenesis.

Sample treatment method for removing glycosyl by selective photocatalysis of glycosphingolipid and mass spectrometric detection method

The invention relates to a sample treatment method for selectively removing glycosyl from glycosphingolipid through photocatalysis and a mass spectrometric detection method. The sample treatment method specifically comprises the following steps: (1) dissolving a sample in an alkaline protic solvent; (2) dispersing titanium dioxide particles; and (3) carrying out photocatalytic reaction under ultraviolet irradiation, and centrifuging to obtain a sample solution subjected to photocatalytic treatment. The mass spectrometric detection method specifically comprises the following steps: injecting a sample solution subjected to photocatalysis treatment into a mass spectrum, carrying out primary mass spectrometric detection, and carrying out comparison data analysis on the sample solution subjected to photocatalysis treatment and a sample extracting solution not subjected to photocatalysis treatment, a primary mass spectrum peak which is possibly a glycolipid decomposition product is screened through comparison and analysis results, and secondary mass spectrum detection is further carried out, so that the accurate molecular structure of glycolipid is analyzed. According to the method, the glycosyl head of glycolipid can be selectively, rapidly and efficiently removed in the presence of complex lipidomes, subsequent mass spectrum detection analysis is carried out, glycolipid spectrum peaks in complex mass spectrum peaks can be effectively, rapidly and accurately found out by comparing the mass spectrum peaks before and after removal, and the detection result is accurate. Important chemical information is provided for rapid locking of correct candidate substances in the first-level mass spectrum qualitative process, and meanwhile, the glycolipid decomposition product can obtain carbon chain structure information which is richer than that of original glycolipid to assist qualitative analysis.
Owner:CENT SOUTH UNIV

Lipid in-situ mass spectrometry method and device based on online selective enrichment-optical desorption

The invention relates to the technical field of chemical substance detection, in particular to a lipid in-situ mass spectrometry method and device based on online selective enrichment-photoanalysis, and the method comprises the following steps: (1) extracting lipid in a sample into an alkaline protic solvent by adopting an in-situ liquid extraction technology to obtain an in-situ extraction system solution; (2) sucking the in-situ extraction system solution through a transmission pipeline under vacuum or negative pressure, and leading the in-situ extraction system solution to a mass spectrum for mass spectrum detection, wherein a titanium dioxide nano-particle coating is arranged in the transmission pipeline; and (3) after the lipid mass spectrum band in the in-situ extraction system solution is completely subjected to mass spectrum detection, irradiating the titanium dioxide nano-particle coating by adopting an ultraviolet lamp, continuously introducing the alkaline protic solvent, sucking the alkaline protic solvent through a transmission pipeline, and introducing the alkaline protic solvent to a mass spectrum for mass spectrum detection. According to the method disclosed by the invention, online selective enrichment of glycolipid can be realized while in-situ liquid extraction is carried out, meanwhile, the glycosphingolipid is directly analyzed by using ultraviolet light under the condition that solvent switching is not needed, the analysis rate of the glycosphingolipid on the surface of titanium dioxide and the operation convenience are greatly improved, and finally, the detection sensitivity of the glycosphingolipid is improved.
Owner:CENT SOUTH UNIV

Sialylation of glycosphingolipids

The present invention relates to a method for the production of a sialylated glycosphingolipid, the method comprising the steps of: ─ providing a glycosphingolipid, a sialic acid donor, and an enzyme having a trans-sialidase activity, ─ mixing said glycosphingolipid with said sialic acid donor in the presence of said enzyme having trans-sialidase activity, thereby producing said sialylated glycosphingolipid, and wherein the sialic acid donor is 3´-sialyllactose.
Owner:CARBOCODE SA

Fused pyrazole amide analogs as glucosylceramide synthase inhibitors

PendingUS20250171467A1Organic active ingredientsOrganic chemistryCystic diseaseLysosome
The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and / or other glucosylceramide-based glycosphingolipids (GSLs).
Owner:MERCK SHARP & DOHME LLC

Detection method for determining amino acid in compound encephalokinin injection by LC-MS (liquid chromatography-mass spectrometry) method

The invention provides a method for detecting amino acid in a compound encephalokinin injection by using an LC-MS (Liquid Chromatography-Mass Spectrometry) method, which has the characteristics of simplicity and convenience in operation, and good precision, stability and recovery rate. The method can be used for detecting the content of 13 amino acids in the compound brain peptide injection, including histidine, phenylalanine, lysine, tyrosine, asparagine, methionine, valine, leucine, serine, arginine, proline, alanine and isoleucine. The detection method is high in detection sensitivity and can be applied to internal quality component research, intermediate component control and quality identification of the product. The detection method can also be used for evaluating the inherent quality of the compound encephalokinin injection, further ensuring the stability of the inherent quality of the product and providing technical reference.
Owner:JILIN TIANCHENG PHARM CO LTD

A nanoliposome containing sea cucumber ganglioside extract with neuroprotective activity and its preparation method

This invention provides a sea cucumber ganglioside extract nanoliposome with neuroprotective activity and its preparation method. The preparation steps are as follows: thawed frozen ready-to-eat sea cucumber, chopped, freeze-dried, pulverized, and sieved to obtain freeze-dried powder. The powder is then extracted using supercritical CO2 extraction and rotary evaporation to remove the solvent. This powder is then dissolved in anhydrous ethanol with soybean lecithin and β-sitosterol as the oil phase, mixed with PBS buffer, stirred, and hydrated to obtain a proemulsion. After centrifugation, the precipitate is resuspended and sonicated to obtain the product. This invention uses supercritical CO2 extraction, and the extract contains 59.70 μg / g of gangliosides, with glycosphingolipids accounting for 96.372% of sphingolipids, resulting in enrichment of the target components. Simultaneously, these nanoliposomes significantly delay Aβ1-42-induced paralysis. The 30 μg / mL group showed a 2.75-fold increase in motor ability and a 30% increase in reproductive function compared to the control group, and a 47% reduction in ROS levels. The neuroprotective effect is superior to that of the unencapsulated extract, providing a new approach for adjuvant intervention in neurodegenerative diseases such as Alzheimer's disease, and has broad application prospects in the functional food field.
Owner:SHANGHAI JIAOTONG UNIV +1

Sphingomonas selective culture medium and preparation method thereof

The application belongs to the technical field of microbial separation and culture, and discloses a sphingomonas selective culture medium and a preparation method thereof. The culture medium comprises a basic culture medium, streptomycin and polymyxin B. The final concentration of the streptomycin is 200 μg / mL, and the final concentration of the polymyxin B is 64 μg / mL. Based on the structural characteristics of sphingomonas outer membrane replacing lipopolysaccharide with sphingolipid, the streptomycin and the polymyxin B are used in combination to construct a selective culture medium. Experimental results show that 10 strains of sphingomonas from different sources can grow normally on the culture medium, while bacillus velezensis ( Bacillus velezensis ) 、 ) Pseudomonas lundensis ( Pseudomonas laurentiana ) 、 Agrobacterium sp. ( Agrobacterium pusense ) 、 Escherichia coli ( Escherichia coli ) are completely inhibited. The selective culture medium is significantly superior to the existing single-drug culture medium, and is suitable for efficient separation and screening of sphingomonas in complex environmental samples such as soil, water, sediments and plant rhizosphere.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Arrhythmogenic cardiomyopathy lipid pathogenesis

PCT designated stageWO2026085157A1Cosmetic preparationsToilet preparationsMyocardial fiberGlycosphingolipid
Arrhythmogenic cardiomyopathy (ACM) is a familial heart disease characterized by progressive myocardial fibrofatty infiltration. Compositions in the treatment of fibrofatty accumulation and its pathogenesis in ACM include activators of glycosphingolipid (GSL) glycosyltransferase, β-1,4-galactosyltransferase- V (β-1,4-GalT-V).
Owner:JOHNS HOPKINS UNIVERSITY

Methods for increasing embryo implantation rate or fertility rate

The present invention provides methods for increasing embryo implantation rate of a subject, comprises the step of administering a composition comprising an effective amount of a glycosphingolipid. Also provided are methods for increasing embryo implantation rate in a subject, comprises the step of administering at least one embryo that expresses a glycosphingolipid.
Owner:CHANG GUNG MEMORIAL HOSPITAL +1

Extraction method of plant glycosphingolipid

The invention provides a plant glycosphingolipid extraction method, which comprises: taking a plant material, grinding liquid nitrogen, adding a hot ethanol solution (containing beta-mercaptoethanol), carrying out oscillation extraction at a high temperature, carrying out high-temperature high-speed centrifugation, taking the supernatant, carrying out low-temperature precipitation, and carrying out high-speed centrifugation to obtain a crude extract; washing the crude extract with acetone and diethyl ether, removing the organic solvent through high-speed centrifugation, adding a dissolving solution (tetrahydrofuran, methanol and water), carrying out vortex uniform mixing, carrying out high-temperature dissolution, filtering, and carrying out vacuum centrifugal drying on the filtrate to obtain a crude product; adding n-butyl alcohol and water into the crude product, dissolving, precipitating and centrifuging at high temperature, taking an upper layer n-butyl alcohol phase, and performing vacuum centrifugal drying to obtain a target product. The extraction method provided by the invention has the advantages of high extraction efficiency and time saving, and more importantly, small-weight plant material extraction can be effectively realized by virtue of simple equipment, and the sample size required by mass spectrum identification of GIPCs composition and ion chromatography identification of GIPCs glycosyl composition can be obtained.
Owner:INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI

Glycosphingolipid derivative as well as preparation method and application thereof

The invention relates to a glycosphingolipid derivative as well as a preparation method and application thereof. Pulullan is activated, DMEDA is adopted to selectively remove part of acetyl, trichloroacetonitrile (Cl3CCN) is introduced to generate an active intermediate, meanwhile, hydroxyl of phytosphingosine is protected to form a stable ketal structure, and side reaction is avoided. Activated pullulan and hydroxyl-protected phytosphingosine are subjected to a condensation reaction under the action of an acid catalyst, and then high-purity glycosphingolipid derivatives are prepared through deprotection treatment and purification. The compound has excellent amphipathy, shows good moisturizing performance and light aging resistance, and can be widely applied to the fields of cosmetics, medicines and functional materials. The method has the advantages of mild reaction conditions and high efficiency, and avoids the problems of poor reaction selectivity and many impurities in the traditional technology.
Owner:DIDI (NANJING) BIOTECHNOLOGY CO LTD

Composition comprising glycosphingolipids for toddler applications

PendingCN121889052AOrganic active ingredientsDigestive systemGastrointestinal inflammationNutrition
A composition for young children comprising glycosphingolipids. The present invention relates to a composition comprising one or more glycosphingolipids, to a nutritional formula for children comprising said composition, to the use of said composition for supporting healthy growth and development of young children, in particular infants, and for dietary management of symptoms related to inflammation of the gastrointestinal tract system of said young children. In particular, the present invention relates to a composition comprising one or more compounds of formula (1) or salts thereof: wherein R1 is a C13-C17 alkyl chain; r2 is a C15-C19 alkyl chain; and R3 is a glycosyl moiety selected from Neu5Ac [alpha] 2-3-Gal [beta] 1-4-Glc [beta] 1-or Neu5Ac [alpha] 2-8-Neu5Ac [alpha] 2-3-Gal [beta] 1-4-Glc [beta] 1-. Children's nutritional formulas comprising the composition are also provided.
Owner:CARBON CODE JOINT CO LTD

Method for the isolation of glycosphingolipids

PCT designated stage expiredWO2025032499A2MembranesSemi-permeable membranesGlycosphingolipidAcyl group
The present invention describes a novel method for the isolation of a glycosphingolipid lacking the amide-linked fatty acyl group, the method comprising the steps of: providing a solution comprising said glycosphingolipid of formula (1) or a salt thereof, and one or more contaminants, diafiltration of said solution, thereby obtaining a diafiltration retentate (DFR) comprising said glycosphingolipid, or salt thereof, by using a membrane having a MWCO of 100-300 kDa, thereby isolating said glycosphingolipid or salt thereof from the one or more contaminants.
Owner:CARBOCODE SA

Composition comprising glycosphingolipids

A composition comprising one or more compounds of formula (1), or salts thereof: (1) wherein R1 is a C13-C17 alkyl chain; R2 is a C15-C19 alkyl chain, preferably C18; and R3 is a glycosyl moiety selected from Neu5Acα2-3-Galβ1-4-Glcβ1-, or Neu5Acα2-8-Neu5Acα2-3- Galβ1-4-Glc β1-. Child nutritional formulas containing the composition are also provided.
Owner:CARBOCODE SA

Non-aromatic cyclic-pyrimidine analogs as glucosylceramide synthase inhibitors

PendingUS20250188057A1Organic active ingredientsNervous disorderCystic diseaseLysosome
The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and / or other glucosylceramide-based glycosphingolipids (GSLs).
Owner:MERCK SHARP & DOHME LLC

Sialylation of glycosphingolipids

PendingCN121620596AOrganic active ingredientsSugar derivativesSialic acidGlycosphingolipid
The present invention relates to a method for producing a sialylated glycosphingolipid, comprising the steps of:-providing a glycosphingolipid, a sialic acid donor and an enzyme having transsialidase activity,-mixing the glycosphingolipid with the sialic acid donor in the presence of the enzyme having transsialidase activity, the sialylated glycosphingolipid is a sialylated glycosphingolipid, and wherein the sialic acid donor is 3 '-sialylated lactose.
Owner:CARBON CODE JOINT CO LTD

Soothing face cream with moisturizing function and preparation method thereof

The invention discloses soothing face cream with a moisturizing function and a preparation method of the soothing face cream, and belongs to the technical field of cosmetic face cream. Comprising the following components in percentage by mass: 3%-5% of a hydrogenated styrene-butadiene block copolymer, 2%-4% of isopropyl myristate, 1%-3% of glycosphingolipids, 2%-4% of dipolypentaerythritol hexanoate, 1%-3% of c12 / 13 alcohol lactate, 0.5%-1.5% of tocopheryl acetate, 0.1%-0.5% of bisabolol, 2%-5% of a fermentation extract and the balance of water. 1%-3% of a kosteletzkya virginica extract, 0.5%-1.5% of an embelia fortuneana extract, 0.5%-1.5% of an apium graveolens seed extract, 0.5%-1.5% of an astragalus membranaceus extract, 0.5%-1.5% of a phellodendron amurense bark extract, 2-5% of a vegetable oil composite liquid crystal emulsifier, 8%-15% of a humectant, 0.3%-0.8% of a preservative, 0.05%-0.15% of disodium EDTA and the balance of water. According to the invention, rape oil amide propyl-dimethylamine is prepared into a vegetable oil composite liquid crystal emulsifier to be applied to a face cream formula, an oil-in-water emulsion system with efficient moisturizing and relieving effects and strong stability is constructed, good smearing property and rapid absorbability of the face cream are realized, and the durability of the moisturizing and relieving effects of the face cream is remarkably improved.
Owner:MAEN MEDICAL CLOUD (CHONGQING) DIGITAL MEDICAL TECHNOLOGY CO LTD

Biological production of gangliosides in recombinant host cells

PendingCN120858172AFungiTransferasesGlycosphingolipidPharmaceutical drug
In various embodiments, provided herein are host cells, methods, and pharmaceutical compositions, including complex sphingolipids, such as monosialic acid ganglioside 1 (GM1), monosialic acid ganglioside 2 (GM2), and monosialic acid ganglioside 3 (GM3). In some embodiments, the present disclosure provides biological production of glycosphingolipids. In still further embodiments, the present disclosure provides for the biological production of gangliosides.
Owner:RECOMBIA BIOSCIENCES INC

A sample processing method and mass spectrometry detection method for selective photocatalytic deglycosylation of glycosphingolipids

The application relates to a sample processing method and a mass spectrometry detection method for selective photocatalytic desugar of glycosphingolipids. The sample processing method specifically comprises the following steps: (1) dissolving a sample in an alkaline protic solvent; (2) dispersing titanium dioxide particles in the sample; and (3) performing a photocatalytic reaction under ultraviolet light irradiation, centrifuging, and obtaining a photocatalytically processed sample solution. The mass spectrometry detection method specifically comprises the following steps: feeding the photocatalytically processed sample solution into a mass spectrometer to perform primary mass spectrometry detection, comparing the photocatalytically processed sample solution with a sample extraction solution without photocatalytic processing, screening a primary mass spectrometry peak that may be a glycolipid decomposition product through comparative analysis, and performing further secondary mass spectrometry detection to analyze the accurate molecular structure of the glycolipid. The method can selectively and rapidly and efficiently remove the sugar group head of glycolipids in the presence of complex lipid groups, and can be used for subsequent mass spectrometry detection and analysis. Through comparison of mass spectrometry peaks before and after removal, glycolipid peaks in complex mass spectrometry peaks can be effectively and rapidly and accurately found, important chemical information for rapid locking of correct candidate substances in the primary mass spectrometry qualitative process is provided, and glycolipid decomposition products can also obtain more abundant carbon chain structure information than original glycolipids to assist in qualitative analysis.
Owner:CENT SOUTH UNIV

Short chain ceramide-based lipids and uses thereof

Provided herein, in some aspects, are delivery vehicles comprising a glycosphingolipid and an agent to be delivered attached to the glycosphingolipid. In some embodiments, the glycosphingolipid comprises an oligosaccharide and a short chain (e.g., C0-C3) ceramide. In some embodiments, the agent to be delivered is a therapeutic agent. The glycosphingolipid is able to deliver the agent to a cell or to a cellular compartment, as well as across the musical barrier. In some embodiments, agents delivered using the glycosphingolipid described herein exhibit longer half-life, compared to agents delivered alone. Methods of delivering a therapeutic agent to a subject for treating a disease using the glycosphingolipid delivery vehicle are also provided.
Owner:CHILDRENS MEDICAL CENT CORP

Modified imidazopyridines as glucosylceramide synthase inhibitors

ActiveUS12559491B2Organic chemistryCystic diseaseLysosome
The present invention relates to Compounds of Formula I: I and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and / or other glucosylceramide-based glycosphingolipids (GSLs).
Owner:MERCK SHARP & DOHME LLC

Method for the isolation of glycosphingolipids

PCT designated stage expiredWO2025032499A3MembranesSemi-permeable membranesGlycosphingolipidAcyl group
The present invention describes a novel method for the isolation of a glycosphingolipid lacking the amide-linked fatty acyl group, the method comprising the steps of: providing a solution comprising said glycosphingolipid of formula (1) or a salt thereof, and one or more contaminants, diafiltration of said solution, thereby obtaining a diafiltration retentate (DFR) comprising said glycosphingolipid, or salt thereof, by using a membrane having a MWCO of 100-300 kDa, thereby isolating said glycosphingolipid or salt thereof from the one or more contaminants.
Owner:CARBOCODE SA

Phytosterol ester / oryzanol self-assembled gel as well as preparation method and application thereof

The invention discloses phytosterol ester oryzanol self-assembled gel and a preparation method and application thereof, and the preparation method comprises the following steps: drying rice germs, extruding the dried rice germs into rice germ cakes, and squeezing the rice germ cakes to obtain coarse rice germ oil; inoculating the coarse rice germ oil with yeast for fermentation, and filtering to obtain the gamma-oryzanol-containing rice germ oil; the preparation method comprises the following steps: adding water, polypeptide, an emulsifier and glycosphingolipids into gamma-oryzanol-containing rice germ oil, and emulsifying to obtain an emulsion; the phytosterol ester is added into the emulsion, heat preservation is performed for a period of time after heating and stirring, heat preservation is performed after cooling, and the phytosterol ester / oryzanol self-assembled gel is obtained and can be used as a skin brightening, anti-wrinkle repairing or moisturizing raw material, and the self-assembled gel has multiple active component molecules, has a synergistic water locking function, and has the functions of whitening, whitening, moisturizing and the like. Therefore, the skin-care product can be used as a raw material of cosmetics or skin care products.
Owner:HANGZHOU FORMULATOR TECH CO LTD

Fused pyrazole urea analogs as glucosylceramide synthase inhibitors

PendingUS20250026762A1Organic active ingredientsOrganic chemistryCystic diseaseLysosome
The present invention relates to Compounds of Formula (I) and pharmaceutically acceptable salts or prodrug thereof. The present invention also relates to compositions comprising at least one compound of Formula (I), and methods of using the compounds of Formula (I) for treatment or prophylaxis of lysosomal storage diseases, neurodegenerative disease, cystic disease, cancer, or a diseases or disorders associated with elevated levels of glucosylceramide (GlcCer), glucosylsphingosine (GlcSph) and / or other glucosylceramide-based glycosphingolipids (GSLs).
Owner:MERCK SHARP & DOHME LLC

Cosmetic composition in form of cream-gel for skin cleansing

ActiveRU2865726C1ArginineGlycerol
FIELD: cosmetics.SUBSTANCE: cosmetic composition in the form of a cream-gel for skin cleansing contains purified water; an emulsifier consisting of cetyl alcohol, glyceryl stearate, PEG-75 stearate, ceteth-20 and steareth-20; glycerin; coco-glucoside; a co-surfactant consisting of purified water, glyceryl oleate and coco-glucoside; cetearyl alcohol; caprylic / capric triglyceride; panthenol; butylene glycol; squalane; oat extract; sodium acrylate / sodium acryloyldimethyl taurate copolymer; cocamidopropyl betaine; cholesterol; ceramide complex including: ceramides NP, AP, AS, NG, glycosphingolipids, hydrogenated lecithin and auxiliary components; fructooligosaccharides; hydroxyacetophenone; preservative consisting of 1,2-hexanediol and caprylyl glycol; tocopheryl acetate; fragrance; arginine and disodium EDTA, in a certain ratio of components, wt.%.EFFECT: relisble removal of impurities from the skin's surface, restoration of the damaged protective barrier of the skin during washing without causing excessive dryness of the skin, relief of irritation and moisturization of the skin.1 cl, 3 tbl, 4 ex
Owner:OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOSTYU GELTEK-MEDIKA

Method for extracting ceramide and glycosphingolipid from liquor byproduct waste

The invention discloses a method for extracting ceramide and glycosphingolipid from the byproduct of liquor, the waste lees, and belongs to the technical field of compound extraction. The invention provides a method for extracting ceramide and glycosphingolipid, which uses the byproduct of liquor, the waste lees, as raw materials, and sequentially undergoes the steps of drying, extraction, alkali adjustment, filtration, acid adjustment, concentration, extraction, recrystallization, etc., to finally obtain free ceramide and glycosphingolipid. The invention extracts ceramide and glycosphingolipid with high economic value from the byproduct of liquor, turns waste into treasure, recycles resources, improves resource utilization, and has significant economic and environmental benefits.
Owner:WULIANGYE +1

Methods for identifying and treating disease

PendingCN119256228ACompound screeningApoptosis detectionDiseaseGlycosphingolipid
Methods for assessing abnormal glycosphingolipid processing, as well as methods for determining the severity and / or progression of a disease associated therewith, are provided. Also provided are methods for assessing the possible therapeutic response of a subject to treatment with an agent capable of modulating processing of glycosphingolipids, as well as methods of treatment that benefit from assessing a patient according to the present disclosure. The methods of the present disclosure employ an agent capable of stimulating the glycosphingolipid pathway in a cell (e.g., cyclohexentetrol-beta epoxide), and then monitor the recovery of the cell, e.g., monitor the recovery of glycosphingolipid flux in the cell.
Owner:GENZYME CORP

Ophthalmic devices for delivery of hydrophobic comfort agents

The invention relates to a soft hydrogel contact lens, especially a silicone hydrogel contact lens, which has a capability of delivering a hydrophobic comfort agent into the eye of a wearer. The hydrophobic comfort agent includes without limitation a monoglyceride, a diglyceride, a triglyceride, a glycolipid, a glyceroglycolipid, a sphingolipid, a sphingo-glycolipid, a phospholipid, a fatty acid, a fatty alcohol, a hydrocarbon having a C12-C28 chain in length, a mineral oil, a silicone oil, or a mixture thereof. It can be released from the soft hydrogel contact lens into the eye of a wearer when being worn so as to strengthen and stabilize the tear film lipid layer and alleviate the dryness of the eye.
Owner:ALCON INC